↓ Skip to main content

Treatment for lupus nephritis

Overview of attention for article published in Cochrane database of systematic reviews, December 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (94th percentile)
  • Good Attention Score compared to outputs of the same age and source (72nd percentile)

Citations

dimensions_citation
57 Dimensions

Readers on

mendeley
93 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Treatment for lupus nephritis
Published in
Cochrane database of systematic reviews, December 2012
DOI 10.1002/14651858.cd002922.pub3
Pubmed ID
Authors

Lorna Henderson, Philip Masson, Jonathan C Craig, Robert S Flanc, Matthew A Roberts, Giovanni FM Strippoli, Angela C Webster

Abstract

Cyclophosphamide, in combination with corticosteroids has been used to induce remission in proliferative lupus nephritis, the most common kidney manifestation of the multisystem disease, systemic lupus erythematosus. Cyclophosphamide therapy has reduced mortality from over 70% in the 1950s and 1960s to less than 10% in recent years. Cyclophosphamide combined with corticosteroids preserves kidney function but is only partially effective and may cause ovarian failure, infection and bladder toxicity. Several new agents, including mycophenolate mofetil (MMF), suggest reduced toxicity with equivalent rates of remission. This is an update of a Cochrane review first published in 2004.

Twitter Demographics

The data shown below were collected from the profiles of 7 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 93 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Italy 1 1%
Colombia 1 1%
Unknown 91 98%

Demographic breakdown

Readers by professional status Count As %
Researcher 15 16%
Student > Postgraduate 12 13%
Student > Master 12 13%
Student > Bachelor 10 11%
Student > Ph. D. Student 9 10%
Other 35 38%
Readers by discipline Count As %
Medicine and Dentistry 55 59%
Unspecified 13 14%
Nursing and Health Professions 6 6%
Psychology 3 3%
Agricultural and Biological Sciences 3 3%
Other 13 14%

Attention Score in Context

This research output has an Altmetric Attention Score of 20. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 May 2016.
All research outputs
#687,808
of 12,533,317 outputs
Outputs from Cochrane database of systematic reviews
#2,380
of 10,346 outputs
Outputs of similar age
#14,291
of 257,586 outputs
Outputs of similar age from Cochrane database of systematic reviews
#144
of 527 outputs
Altmetric has tracked 12,533,317 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 10,346 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 20.2. This one has done well, scoring higher than 76% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 257,586 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 527 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.